Actively Recruiting
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Led by Mayo Clinic · Updated on 2026-02-27
25
Participants Needed
1
Research Sites
93 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To evaluate the effect of CS reducer implantation in patients with HFPEF and CMD on myocardial ischemia, measured by stress myocardial perfusion using cardiovascular magnetic resonance (CMR)
CONDITIONS
Official Title
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 6518 years
- Enrollment in main CS-reducer HFPEF study IRB# 25-002292
You will not qualify if you...
- Metal implants that are not suitable for MRI
- Inability or unwillingness to give written informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
D
Diana Albers
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here